Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vender

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 18, 2014
Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trialC Conrad, J Lymp, V Thompson, et al.
Science Advances|June 12, 2020
Neutrophil extracellular traps exacerbate neurological deficits after traumatic brain injuryKumar Vaibhav, Molly Braun, Katelyn Alverson, et al.
The British Journal of Dermatology|September 4, 2020
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trialA Blauvelt, C Leonardi, B Elewski, et al.
The Journal of Experimental Medicine|September 8, 2018
Remote ischemic post-conditioning promotes hematoma resolution via AMPK-dependent immune regulationKumar Vaibhav, Molly Braun, Mohammad Badruzzaman Khan, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 18, 2014
Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trialC Conrad, J Lymp, V Thompson, et al.
Science Advances|June 12, 2020
Neutrophil extracellular traps exacerbate neurological deficits after traumatic brain injuryKumar Vaibhav, Molly Braun, Katelyn Alverson, et al.
The British Journal of Dermatology|September 4, 2020
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trialA Blauvelt, C Leonardi, B Elewski, et al.
The Journal of Experimental Medicine|September 8, 2018
Remote ischemic post-conditioning promotes hematoma resolution via AMPK-dependent immune regulationKumar Vaibhav, Molly Braun, Mohammad Badruzzaman Khan, et al.
Pageof 8